Clinical Trial Update: Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating tau protein levels in the brains of participants with Alzheimer disease compared to healthy participants. The sponsor is J…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Alzheimer Disease | EARLY_Phase 1 | Status: COMPLETED